Longitudinal changes in social functioning in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: Results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study (II)

Quality of Life Research

Volumn 21, Issue 7, 2012, Pages 1111-1121

  Patti, Francesco ^a,b   Amato, Maria Pia ^c   Trojano, Maria ^d   Bastianello, Stefano ^e   Tola, Maria Rosalia ^f   Picconi, Orietta ^g   Cilia, Sabina ^g   Cottone, Salvatore ^h   Grimaldi, Luigi M E ⁱ  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY OF BARI   (Italy)

^e C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^f Azienda Università Ospedale   (Italy)

^g Opera CRO Scientific Advisory Board   (Italy)

^h Centro Di Riferimento Regionale di Neuroimmunologia   (Italy)

ⁱ Fondazione Istituto S Raffaeleg Giglio   (Italy)

Author keywords

Cognitive function; Interferon b 1a; Quality of life; Relapsing remitting multiple sclerosis; Social interaction; Social isolation

Indexed keywords

BETA INTERFERON; BETA1A INTERFERON; IMMUNOLOGIC FACTOR;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL (TOPIC); COGNITION; DISABLED PERSON; FEMALE; HUMAN; HUMAN RELATION; LONGITUDINAL STUDY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CLINICAL TRIALS AS TOPIC; COGNITION; DISABLED PERSONS; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-BETA; INTERPERSONAL RELATIONS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; QUALITY OF LIFE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84867067406     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-011-0021-6     Document Type: Article

References (43)

1. Foley, J. F., & Brandes, D. W. (2009). Redefining functionality and treatment efficacy in multiple sclerosis. Neurology, 72, S1-S11.
2. Turpin, K. V., Carroll, L. J., Cassidy, J. D., & Hader, W. J. (2007). Deterioration in the health-related quality of life of persons with multiple sclerosis: The possible warning signs. Multiple Sclerosis, 13, 1038-1045.
3. Rothwell, P. M., McDowell, Z., Wong, C. K., & Dorman, P. J. (1997). Doctors and patients don't agree: Cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis. British Medical Journal, 314, 1580-1583.
4. Mitchell, A. J., Benito-Leon, J., Gonzalez, J. M., & Rivera- Navarro, J. (2005). Quality of life and its assessment in multiple sclerosis: Integrating physical and psychological components of wellbeing. Lancet Neurology, 4, 556-566.
5. Benito-Leon, J., Morales, J. M., & Rivera-Navarro, J. (2002). Health-related quality of life and its relationship to cognitive and emotional functioning in multiple sclerosis patients. European Journal of Neurology, 9, 497-502.
6. Miller, D. M., Rudick, R. A., Baier, M., Cutter, G., Doughtery, D. S., Weinstock-Guttman, B., et al. (2003). Factors that predict health-related quality of life in patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis, 9, 1-5.
7. Patti, F., Amato, M. P., Trojano, M., Bastianello, S., Tola, M. R., Picconi, O., et al. (2011). Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study. Multiple Sclerosis, 17, 991-1001.
8. Hakim, E. A., Bakheit, A. M., Bryant, T. N., Roberts, M. W., Intosh-Michaelis, S. A., Spackman, A. J., et al. (2000). The social impact of multiple sclerosis - A study of 305 patients and their relatives. Disability and Rehabilitation, 22, 288-293.
9. Ford, H. L., Gerry, E., Johnson, M. H., & Tennant, A. (2001). Health status and quality of life of people with multiple sclerosis. Disability and Rehabilitation, 23, 516-521.
10. Confavreux, C., Vukusic, S., Moreau, T., & Adeleine, P. (2000). Relapses and progression of disability in multiple sclerosis. New England Journal of Medicine, 343, 1430-1438.
11. Goretti, B., Ghezzi, A., Portaccio, E., Lori, S., Zipoli, V., Razzolini, L., et al. (2010). Psychosocial issue in children and adolescents with multiple sclerosis. Neurological Sciences, 31, 467-470.
12. Kotterba, S., Orth, M., Eren, E., Fangerau, T., & Sindern, E. (2003). Assessment of driving performance in patients with relapsing-remitting multiple sclerosis by a driving simulator. European Neurology, 50, 160-164.
13. Morrow, S. A., Drake, A., Zivadinov, R., Munschauer, F., Weinstock-Guttman, B., & Benedict, R. H. (2010). Predicting loss of employment over three years in multiple sclerosis: Clinically meaningful cognitive decline. The Clinical Neuropsychologist, 24, 1131-1145.
14. Rao, S. M., Leo, G. J., Ellington, L., Nauertz, T., Bernardin, L., & Unverzagt, F. (1991). Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology, 41, 692-696.
15. Amato, M. P., Ponziani, G., Siracusa, G., & Sorbi, S. (2001). Cognitive dysfunction in early-onset multiple sclerosis: A reappraisal after 10 years. Archives of Neurology, 58, 1602-1606.
16. Vanner, E. A., Block, P., Christodoulou, C. C., Horowitz, B. P., & Krupp, L. B. (2008). Pilot study exploring quality of life and barriers to leisure-time physical activity in persons with moderate to severe multiple sclerosis. Disability and Health Journal, 1, 58-65.
17. Thompson, A. J. (1999). Measuring handicap in multiple sclerosis. Multiple Sclerosis, 5, 260-262.
18. Mellerup, E., Fog, T., Raun, N., Colville, P., De Rham, B., Hannah, B., et al. (1981). The socio-economic scale. Acta Neurologica Scandinavica, 64, 130-138.
19. Stewart, G., Kidd, D., & Thompson, A. J. (1995). The assessment of handicap: An evaluation of the Environmental Status Scale. Disability and Rehabilitation, 17, 312-316.
20. Fog, T., Heltberg, A., Kyhn, K., Mellerup, E., Raun, N. E., & Zeeberg, I. (1984). Evaluation of disability, incapacity and environmental status scales in multiple sclerosis. Acta Neurologica Scandinavica Supplement, 101, 77-86.
21. Patti, F., Amato, M., Trojano, M., Bastianello, S., Tola, M., Goretti, B., et al. (2009). Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsingremitting multiple sclerosis: Baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. Multiple Sclerosis, 15, 779-788.
22. Patti, F., Amato, M. P., Bastianello, S., Caniatti, L., Di Monte, E., Ferrazza, P., et al. (2010). Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis, 16, 68-77.
23. McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H. P., Lublin, F. D., et al. (2001). Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Annals of Neurology, 50, 121-127.
24. Polman, C. H., Reingold, S. C., Edan, G., Filippi, M., Hartung, H. P., Kappos, L., et al. (2005). Diagnostic criteria for multiple sclerosis: 2005 revisions to the ''McDonald Criteria''. Annals of Neurology, 58, 840-846.
25. American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) (4th ed.). Washington DC: American Psychiatric Publishing, Inc.
26. Rao, S. M., Leo, G. J., Bernardin, L., & Unverzagt, F. (1991). Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology, 41, 685-691.
27. Barbarotto, R., Laiacona, M., Frosio, R., Vecchio, M., Farinato, A., & Capitani, E. (1998). A normative study on visual reaction times and two Stroop colour-word tests. Italian Journal of Neurological Sciences, 19, 161-170.
28. Amato, M. P., Portaccio, E., Goretti, B., Zipoli, V., Ricchiuti, L., De Caro, M. F., et al. (2006). The Rao's Brief Repeatable Battery and Stroop test: Normative values with age, education and gender corrections in an Italian population. Multiple Sclerosis, 12, 787-793.
29. Vickrey, B. G., Hays, R. D., Harooni, R., Myers, L. W., & Ellison, G. W. (1995). A health-related quality of life measure for multiple sclerosis. Quality of Life Research, 4, 187-206.
30. Hamilton, M. (1967). Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology, 6, 278-296.
31. Colombo, L., Sartori, G., & Brivio, C. (2002). La stima del quoziente intellettivo tramite l'applicazione del TIB (Test di Intelligenza Breve). Giornale Italiano di Psicologia, 3, 613-637.
32. Fisk, J. D., Ritvo, P. G., Ross, L., Haase, D. A., Marrie, T. J., & Schlech, W. F. (1994). Measuring the functional impact of fatigue: Initial validation of the fatigue impact scale. Clinical Infectious Diseases, 18(Suppl. 1), S79-S83.
33. Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003). Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Medical Care, 41, 582-592.
34. Pina Latorre, M. A., Ara, J. R., Modrego, P. J., & Martin, M. (2001). Evaluation of handicap and socio-economic status in patients with multiple sclerosis - Data from a population-based survey in the sanitary area of Calatayud, northern Spain. Wiener Medizinische Wochenschrift, 151, 224-227.
35. Amato, M. P., Zipoli, V., Goretti, B., Portaccio, E., De Caro, M. F., Ricchiuti, L., et al. (2006). Benign multiple sclerosis: Cognitive, psychological and social aspects in a clinical cohort. Journal of Neurology, 253, 1054-1059.
36. Sumowski, J. F., Wylie, G. R., DeLuca, J., & Chiaravalloti, N. (2010). Intellectual enrichment is linked to cerebral efficiency in multiple sclerosis: Functional magnetic resonance imaging evidence for cognitive reserve. Brain, 133, 362-374.
37. Sumowski, J. F., Wylie, G. R., Chiaravalloti, N., & DeLuca, J. (2010). Intellectual enrichment lessens the effect of brain atrophy on learning and memory in multiple sclerosis. Neurology, 74, 1942-1945.
38. Benedict, R. H., Morrow, S. A., Weinstock-Guttman, B., Cookfair, D., & Schretlen, D. J. (2010). Cognitive reserve moderates decline in information processing speed in multiple sclerosis patients. Journal of the International Neuropsychological Society, 16, 829-835.
39. Banati, M., Sandor, J., Mike, A., Illes, E., Bors, L., Feldmann, A., et al. (2010). Social cognition and theory of mind in patients with relapsing-remitting multiple sclerosis. European Journal of Neurology, 17, 426-433.
40. Patti, F., Amato, M. P., Tola, M. R., Trojano, M., Ferrazza, P., Picconi, O., et al. (2008). Cognitive impairment, social functioning and fatigue in patients with relapsing-remitting multiple sclerosis: The COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study. Multiple Sclerosis, 14(Suppl. 1), S265.
41. Patti, F., Pozzilli, C., Montanari, E., Pappalardo, A., Piazza, L., Levi, A., et al. (2007). Effects of education level and employment status on HRQoL in early relapsing-remitting multiple sclerosis. Multiple Sclerosis, 13, 783-791.
42. Flensner, G., Ek, A. C., Landtblom, A. M., & Soderhamn, O. (2008). Fatigue in relation to perceived health: People with multiple sclerosis compared with people in the general population. Scandinavian Journal of Caring Sciences, 22, 391-400.
43. Rudick, R. A., Miller, D., Hass, S., Hutchinson, M., Calabresi, P. A., Confavreux, C., et al. (2007). Health-related quality of life in multiple sclerosis: Effects of natalizumab. Annals of Neurology, 62, 335-346.